The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs." The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.
Recent comments
10 weeks 3 days ago
12 weeks 3 days ago
13 weeks 3 days ago
22 weeks 21 hours ago
45 weeks 5 days ago
1 year 8 weeks ago
1 year 16 weeks ago
1 year 16 weeks ago
1 year 18 weeks ago
1 year 22 weeks ago